Takeda Pharmaceutical Total Non-Operating Income/Expense 2010-2024 | TAK
Takeda Pharmaceutical total non-operating income/expense for the twelve months ending June 30, 2024 was $-1.058B, a 6.93% decline year-over-year.
- Takeda Pharmaceutical annual total non-operating income/expense for 2024 was $-1.113B, a 30.3% increase from 2023.
- Takeda Pharmaceutical annual total non-operating income/expense for 2023 was $-0.854B, a 39.37% decline from 2022.
- Takeda Pharmaceutical annual total non-operating income/expense for 2022 was $-1.409B, a 4.77% increase from 2021.